Astrana Health Key Fundamental And Technical Indicators

Stocks . USA . 
Stock . Astrana Health
ASTH Stock   39.30  3.22  8.92%   
Financial ratios for Astrana Health include profitability, liquidity, leverage, and capital-structure metrics. Astrana Health has a profit margin of 0.71%. Return on equity is 4.49%. According to momentum metrics, Astrana Health records the relative strength indicator of 80, consistent with statistically elevated overbought levels. RSI levels this elevated often precede consolidation or pullback phases as buying pressure extends.
Momentum
OversoldOverbought
80 · Strong
As of the 9th of May, Astrana Health is marked at 39.30 per share. Recent trend indicators show Mean Deviation of 2.7, risk adjusted performance of 0.193, and Downside Deviation of 3.59. Trend analytics rely on normalized volatility and volume metrics. Trend metrics are reviewed within historical sector ranges.
Cycles Operators Shifting Impulse Patterns Depth Overlaps Statistics Volatility Volume
Astrana Health's financials reveal operational efficiency, debt management, and growth trajectory. Balance sheet trends and shifts in competitive positioning are captured in the key metrics below: Investors rely on Astrana Health's financial statements to evaluate management effectiveness and capital efficiency.
 Gross Profit
341.53 million
 Profit Margin
0.7%
 Market Capitalization
2.01 billion
 Enterprise Value Revenue
0.82
 Revenue
3.18 billion
Astrana Health presents one hundred twenty measurable fundamental measures spanning income, balance sheet, and cash flow categories. For long-term positioning, confirm how Astrana Health's prevailing metrics compare to the historical baseline from 2010 to 2026 before making allocation decisions. According to the filing dated December 31, 2025, Market Cap is broadly unchanged at $1.22 billion. In addition to that, Enterprise Value is broadly unchanged at $1.87 billion. For custom fundamental screens that go beyond Astrana Health, explore the full Equity Screeners suite.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Profitability
Analysis
Details
Earnings
Projections
Details

Balance Sheet Accounts

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets$2.33 billion$2.22 billion663.7 M
Consistent Growth
Other Current Liabilities$583.88 million$556.08 million126.2 M
Moderate Growth
Total Current Liabilities$646.04 million$615.27 million149.5 M
Moderate Growth
Accounts Payable$4.58 million$3.52 million6.1 M
High Variability
Cash$450.95 million$429.47 million149.4 M
Consistent Growth
Cash And Short Term Investments$450.95 million$429.47 million164.1 M
Consistent Growth
Common Stock Total Equity$30,039.27$54,05033.3 K
High Variability
Common Stock Shares Outstanding51.84 million49.37 million30 M
Moderate Growth
Liabilities And Stockholders Equity$2.33 billion$2.22 billion663.7 M
Consistent Growth
Non Current Liabilities Total$1.1 billion$1.05 billion238.2 M
Moderate Growth
Other Stockholder Equity$494.41 million$470.86 million192.2 M
Consistent Growth
Total Liabilities$1.74 billion$1.66 billion387.7 M
Moderate Growth
Total Current Assets$906.48 million$863.31 million278.6 M
Consistent Growth
Common Stock$35,064.15$49,00036.1 K
High Variability
Short and Long Term Debt Total$1.13 billion$1.08 billion235.2 M
Moderate Growth
Short Term Debt$58.46 million$55.67 million11.9 M
Moderate Growth
Property Plant And Equipment Net$99.15 million$94.43 million34.5 M
Moderate Growth
Non Current Assets Total$1.42 billion$1.36 billion385.1 M
Consistent Growth
Non Current Assets Other$105.39 million$100.37 million19.1 M
Moderate Growth
Net Receivables$427.95 million$407.57 million104.7 M
Consistent Growth
Other Current Assets$27.58 million$26.26 million9.8 M
Consistent Growth
Property, Plant and Equipment (Gross)$128.88 million$122.74 million40.7 M
Consistent Growth
Current Deferred Revenue$1.75 million$1.85 million3.5 M
High Variability
Long Term Debt$1.04 billion$990.9 million211.5 M
Moderate Growth
Good Will$907.14 million$863.94 million226 M
Consistent Growth
Long Term Debt Total$245.59 million$233.9 million103.4 M
Consistent Growth
Capital Surplus$434.82 million$414.11 million181 M
Consistent Growth
Intangible Assets$284.52 million$270.97 million75.8 M
Moderate Growth
Property Plant Equipment$155.74 million$148.33 million50.8 M
Consistent Growth
Other Liabilities$28.24 million$20.97 million26.8 M
High Variability
Short and Long Term Debt$50.26 million$47.87 million11 M
Moderate Growth
Long Term Investments$39.01 million$28.53 million29 M
Moderate Growth
Non Current Liabilities Other$14.62 million$17.11 million13.4 M
High Variability
Warrants$11.7 million$12.31 million118 M
Moderate Decline
Capital Lease Obligations$24.12 million$39.36 million13.3 M
Consistent Growth
Net Invested Capital$1.91 billion$1.82 billion569.7 M
Consistent Growth
Net Working Capital$234.37 million$248.04 million140.8 M
Consistent Growth
Capital Stock$47,916.83$49,00039.6 K
Consistent Growth

Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses$3.26 billion$3.1 billion773.3 M
Consistent Growth
Selling General Administrative$228.12 million$217.26 million60.6 M
Consistent Growth
Total Revenue$3.34 billion$3.18 billion813.4 M
Consistent Growth
Cost Of Revenue$3.03 billion$2.89 billion706.3 M
Consistent Growth
Depreciation And Amortization$48.04 million$45.75 million14.8 M
Consistent Growth
Gross Profit$310.57 million$295.78 million107.1 M
Consistent Growth
Interest Income$12.76 million$12.16 million4.2 M
Moderate Growth
Non Recurring$539,195$567,5731.9 M
High Variability
Reconciled Depreciation$24.68 million$45.75 million21.2 M
High Variability
Extraordinary Items$7.76 million$8.73 million9.5 M
Stable

Cash Flow Statement Items

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow$303.56 million$289.1 million115.6 M
Consistent Growth
End Period Cash Flow$455.75 million$434.05 million149.7 M
Consistent Growth
Depreciation$48.04 million$45.75 million14.8 M
Consistent Growth
Stock Based Compensation$40.53 million$38.6 million10.3 M
Moderate Growth

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.36x0.38x0.9256
High Variability
Dividend Yield0.62%0.65%0.0239
High Variability
PTB Ratio2.331.562.0717
High Variability
Days Sales Outstanding35.7746.7639.3467
High Variability
Book Value Per Share10.8111.385.8 M
Moderate Decline
Stock Based Compensation To Revenue0.01x0.01x0.0067
Moderate Growth
Capex To Depreciation$0.21$0.220.5651
High Variability
PB Ratio2.33x1.56x2.0717
High Variability
Payables Turnover859.9818.95143
Moderate Growth
Sales General And Administrative To Revenue0.11x0.07x0.1797
Moderate Decline
Capex To Revenue0x0x0.0077
High Variability
Cash Per Share8.318.756.3 M
Moderate Decline
Days Payables Outstanding0.420.4513.6086
Moderate Decline
Income Quality$5$4.761.4214
Moderate Growth
EV To Operating Cash Flow$19.68$16.2917.6345
Moderate Growth
EV To Free Cash Flow$24.14$17.8621.0227
Moderate Growth
Intangibles To Total Assets$0.3$0.510.2837
Moderate Growth
Current Ratio2.561.42.1335
High Variability
Receivables Turnover9.947.8110.1938
High Variability
Graham Number$11.08$12.7913.2043
High Variability
Shareholders Equity Per Share15.0915.883.9 M
Moderate Decline
Debt To Equity1.45x1.38x0.4332
Moderate Growth
Capex Per Share0.20.21177.5 K
Moderate Decline
Average Receivables$46.8 million$70.38 million55 M
Moderate Growth
Revenue Per Share61.5964.8329.8 M
Moderate Decline
Interest-Bearing Debt Per Share21.8422.99495 K
Moderate Decline
Debt To Assets0.51x0.49x0.1728
Consistent Growth
Operating Cycle$35.77$46.7639.3467
High Variability
Price Book Value Ratio2.33x1.56x2.0717
High Variability
Days Of Payables Outstanding0.420.4513.6086
Moderate Decline
Ebt Per Ebit$0.48$0.51.052
Moderate Decline
Effective Tax Rate$0.3$0.390.2435
Moderate Growth
Company Equity Multiplier2.81x2.85x2.8387
Moderate Decline
Long Term Debt To Capitalization0.28x0.56x0.2138
Moderate Growth
Total Debt To Capitalization0.61x0.58x0.2286
Consistent Growth
Debt-to-Equity Ratio1.451.380.4332
Moderate Growth
Quick Ratio2.561.42.1335
High Variability
Cash Ratio0.660.71.2515
High Variability
Days Of Sales Outstanding35.7746.7639.3467
High Variability
Free Cash Flow Operating Cash Flow Ratio0.960.910.9634
Moderate Decline
Price To Book Ratio2.33x1.56x2.0717
High Variability
Fixed Asset Turnover20.7433.6928.3784
High Variability
Enterprise Value Multiple11.18x15.02x9.6622
Moderate Growth
Debt Ratio0.510.490.1728
Consistent Growth
Price Sales Ratio0.36x0.38x0.9256
High Variability
Asset Turnover0.941.431.4494
Moderate Decline
Gross Profit Margin8.83%9.30%0.1791
Moderate Decline
Price Fair Value2.33x1.56x2.0717
High Variability

Valuation Indicators

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap$1.04 billion$1.22 billion785.1 M
Moderate Growth

Core Fundamental Drivers

Forward Price Earnings23.0415
Cash And Short Term Investments429.47 million

Current Valuation Driver Correlations

The matrix captures how Current Valuation relates to Astrana Health's other key accounts over time. High correlations narrow the focus to the accounts most relevant when analyzing Current Valuation at Astrana Health.
Click cells to compare fundamentals
Competition

Astrana Health Accumulated Other Comprehensive Income

Accumulated Other Comprehensive Income

$-13.7 million
Accumulated Other Comprehensive Income stood at $-14.42 million as of December 31, 2025.

Astrana Health Fundamental Drivers Relationships

ROE stood at 0.03 as of December 31, 2025. Related reported metric: Return On Asset TTM at 1.06% as of December 31, 2025.

Main Technical Indicators as of May 9, 2026

Cycle Indicators
Math Operators
Math Transform
Momentum Indicators
Overlap Studies
Pattern Recognition
Price Transform
Statistic Functions
Volatility Indicators
Volume Indicators
Risk Adjusted Performance0.193
Market Risk Adjusted Performance-3.37
Mean Deviation2.7
Semi Deviation2.71
Downside Deviation3.59
Coefficient Of Variation521.07
Standard Deviation4.71
Variance22.15
Information Ratio0.1902
Jensen Alpha0.8926
Total Risk Alpha0.9037
Sortino Ratio0.2492
Treynor Ratio-3.38
Maximum Drawdown36.34
Value At Risk-4.57
Potential Upside4.69
Downside Variance12.91
Semi Variance7.35
Expected Short fall-3.02
Skewness3.12
Kurtosis21.01

Daily Market Strength Indicators

Accumulation/Distribution and Balance of Power for Astrana Health reveal whether buying or selling pressure dominates recent sessions. Balance of Power trending positive indicates that buyers are consistently closing Astrana Health near session highs. These signals help explain whether price direction and session structure are moving together for Astrana Health.
Accumulation Distribution100075.0
Daily Balance Of Power0.7368
Rate Of Daily Change1.09
Day Median Price37.72
Day Typical Price38.24
Price Action Indicator3.19
Period Momentum Indicator3.22
Relative Strength Index80.56

Basic Forecasting Models

Volatility clustering is a well-documented feature of Astrana Health Stock price data where periods of large moves tend to follow other large moves. When Astrana Health's RSI reaches extreme levels, it often precedes a short-term price correction or consolidation. Seasonal patterns in Astrana Health's returns tend to persist when driven by structural factors like earnings calendars or index rebalancing.
Naive Prediction
Simple Exponential Smoothing
Double Exponential Smoothing
Triple Exponential Smoothing
Simple Regression
Polynomial Regression
Simple Moving Average
4 Period Moving Average
8 Period Moving Average
20 Period Moving Average

Astrana Health Related Equities

Astrana Health's market space within the Health Care space is illustrated by the firms listed below. Key comparison metrics include price-to-earnings, profit margin, and revenue growth across Astrana Health's peer group.
 Risk & Return  Correlation

Current Valuation Peer Comparison

Peer analysis of Astrana Health using Current Valuation surfaces how it ranks against direct and indirect competitors. Significant differences in Astrana Health's Current Valuation versus peers can highlight competitive strengths or weaknesses. Relative Current Valuation analysis across the peer group reveals valuation patterns that absolute metrics cannot capture.
Astrana Health is currently under evaluation for current valuation among direct rivals.

Important Fundamentals

Return On Equity TTM0.0449
Return On Asset TTM0.0343
Profit Margin TTM0.0071
Operating Margin TTM0.0185
Current Valuation2.6 B
Shares Outstanding55.71 M
Shares Owned By Insiders20.32 %
Shares Owned By Institutions52.67 %
Number Of Shares Shorted2.68 M
Price To Book TTM2.50 X
Price To Sales TTM0.63 X
Revenue TTM3.18 B
Gross Profit TTM341.53 M
EBITDA TTM124.27 M
Net Income TTM24.08 M
Total Debt TTM1.08 B
Book Value Per Share TTM15.94 X
Cash Flow From Operations TTM114.6 M
Short Ratio TTM6.86 X
Earnings Per Share0.46 X
Target Price36.89
Number Of Employees3 K
Trailing Beta0.99
Market Capitalization TTM2.01 B
Total Asset TTM2.22 B
Retained Earnings TTM308.38 M
Working Capital TTM248.04 M
Net Asset2.22 B

Financial Metrics, Fundamentals & Methodology

Astrana Health's operating framework helps explain margin behavior, earnings persistence, and funding capacity. Cash reserves provide a direct read on near-term financial cushion. Astrana Health financial statements report revenue of 3.18 billion, positive EPS of 0.46, operating margin of 1.85% as of the latest reporting period.

Astrana Health metrics draw on periodic company reporting and market reference feeds, standardized for cross-period comparison. Analyst projections are included when active coverage applies. Income statement, balance sheet, and cash-flow values follow GAAP or IFRS conventions as reported.

Editorial review and methodology oversight provided by: Raphi Shpitalnik, Junior Member of Macroaxis Editorial Board


 
Tools
Analysis
Directory
Company
2026 Macroaxis LLC Made with in San Francisco
Privacy Terms Widgets Feedback
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and conditions page.